Increased levels of serum miR-148a-3p are associated with prostate cancer

APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
Sandra Amalie DybosHaakon Skogseth

Abstract

Prostate cancer (PCa) is one of the most common types of cancer and the fifth leading cause of death among men worldwide. The tools for diagnosing PCa have limited value, and to improve correct diagnosis there is a need for markers that can contribute to a more precise diagnosis, which would lead to proper treatment of only those patients who need it. Micro RNA (miRNA) plays a key role in the development of cancer and is therefore a potential marker for PCa. Next-generation sequencing was used to discover differences in miRNA expression between serum samples from PCa patients and healthy controls, and the results were validated by quantitative real-time polymerase chain reaction. Detection of the miRNA of interest was attempted in prostate tissue by in situ hybridization. All samples were collected in collaboration with Biobank1® . By miRNA sequencing of serum samples, significant expression of some miRNAs in patients with PCa and healthy controls was detected. This study showed that miR-148a-3p is upregulated in men with PCa, and the miRNA is differentially expressed in PCa patients compared to healthy controls. The results also showed that miR-148a-3p is located in prostate tissue.

References

Feb 15, 1995·JAMA : the Journal of the American Medical Association·A L PotoskyB S Kramer
Jan 29, 1994·Lancet·G L Lu-Yao, E R Greenberg
Aug 24, 2001·Nature·S M DhanasekaranA M Chinnaiyan
Nov 16, 2002·Proceedings of the National Academy of Sciences of the United States of America·George Adrian CalinCarlo M Croce
Sep 17, 2004·Nature·Victor Ambros
May 4, 2005·Cancer Research·Richard I Gregory, Ramin Shiekhattar
Feb 8, 2006·Proceedings of the National Academy of Sciences of the United States of America·Stefano VoliniaCarlo M Croce
Feb 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Pranidhi SoodNikolaus Rajewsky
Oct 25, 2006·Nature Reviews. Cancer·George A Calin, Carlo M Croce
Jul 10, 2007·Cancer Research·Kati P PorkkaTapio Visakorpi
Jan 2, 2009·Urologic Oncology·Annika SchaeferKlaus Jung
Mar 20, 2009·The New England Journal of Medicine·Gerald L AndrioleUNKNOWN PLCO Project Team
Mar 15, 2011·International Journal of Cancer. Journal International Du Cancer·Sven WachBernd Wullich
Sep 22, 2011·JAMA : the Journal of the American Medical Association·Mehrdad AlemozaffarMartin G Sanda
Oct 8, 2011·PloS One·Akira WatahikiYuzhuo Wang
Nov 5, 2011·International Journal of Cancer. Journal International Du Cancer·Luke A SelthLisa M Butler
Feb 22, 2012·Urologic Oncology·Andreas StensvoldSigbjørn Smeland
Sep 5, 2012·Trends in Biochemical Sciences·Andrey TurchinovichBarbara Burwinkel
Dec 12, 2012·Omics : a Journal of Integrative Biology·Dasong HuaQiang Huang
Mar 20, 2014·JAMA : the Journal of the American Medical Association·Julia H Hayes, Michael J Barry
Sep 5, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Wanli MaMingzhi Gong
May 23, 2015·Nature Reviews. Cancer·Shuibin Lin, Richard I Gregory
May 1, 2014·World Journal of Obstetrics and Gynecology·Sherri L StewartCheryll C Thomas
Jul 9, 2016·Journal of Cancer·Yue LiXiaoning Peng

❮ Previous
Next ❯

Citations

Apr 9, 2020·Epigenomics·Irena AbramovicNino Sincic
Jan 3, 2019·Cytotechnology·Gizem Ors-KumogluCigir Biray-Avci
Sep 6, 2019·Medicina·Ionut Andrei PaunescuCatalin Marian
Aug 10, 2021·Cellular Signalling·Michele Patrícia RodeTânia Beatriz Creczynski-Pasa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.